Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2025-10-29 Share Issue/Capital Cha…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Zawarcie przez dwóch Członków Zarządu umów pożyczek akcji Spółki - Content (PL)
Share Issue/Capital Change Classification · 100% confidence The document describes a transaction involving the lending of shares by company executives (the CEO and Vice President) to an investment bank (Trigon IB) to facilitate an Accelerated Book Building (ABB) process. This involves the movement of shares by directors/executives and relates to capital structure changes. While it involves directors, it is specifically a report on the lending of shares for a financing/capital transaction, which fits the 'Share Issue/Capital Change' (SHA) category as it details the mechanics of share lending in connection with a capital increase.
2025-10-29 Polish
Zakończenie procesu ABB oraz ustalenie ceny emisyjnej i liczby akcji serii K - Content (PL)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Scope Fluidics S.A. detailing the results of an accelerated book-building process (ABB) for the issuance of new Series K shares. It specifies the issue price, the number of shares subscribed, and the impact on the company's share capital. This falls under the category of share issuance and capital changes, as it describes the specific terms and outcome of a new share offering.
2025-10-28 Polish
Zmiana terminu publikacji raportu za III kwartał 2025 r. - Content (PL)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (325 characters) from Scope Fluidics S.A. regarding a change in the scheduled publication date for their Q3 2025 consolidated report. It does not contain the report itself, but rather notifies stakeholders of a shift in the reporting timeline. This fits the definition of a Report Publication Announcement (RPA).
2025-10-27 Polish
Zawarcie umowy mandatowej i rozpoczęcie procesu ABB - Content (PL)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing (raport bieżący) from Scope Fluidics S.A. detailing a capital increase through a private subscription of new shares (Series K) and an accelerated book-building (ABB) process. It covers the issuance of new shares, the involvement of investment banks (Trigon), and lock-up agreements for management. This falls under the category of share issuance and capital changes.
2025-10-27 Polish
Decyzja Zarządu w sprawie podwyższenia kapitału zakładowego w granicach kapitału docelowego z wyłączeniem prawa poboru obecnych akcjonariuszy Spółki - Content (PL)
Capital/Financing Update Classification · 100% confidence The document is a regulatory announcement from Scope Fluidics S.A. detailing the Board's decision to raise capital through the issuance of new shares (Series K) via an Accelerated Book Building (ABB) process. It explicitly discusses the authorization of capital increase, the exclusion of pre-emptive rights, and the engagement of an investment bank (Trigon) to manage the offering. This falls under the category of capital structure changes and financing activities.
2025-10-27 Polish
Aktualizacja informacji nt. współpracy z TE - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement from Scope Fluidics S.A. regarding a material business development involving a partner (microLiquid/TE Connectivity). It describes a potential operational impact on a key project (BACTEROMIC) and outlines the company's mitigation strategy. As it is a specific corporate announcement regarding business operations and potential risks, but does not fit into specific categories like M&A, legal proceedings, or financial reports, it falls under the general regulatory filing category.
2025-10-23 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.